These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21272167)

  • 1. Impaired cellular immune response to diphtheria and tetanus vaccines in children after thoracic transplantation.
    Urschel S; Rieck BD; Birnbaum J; Dalla Pozza R; Rieber N; Januszewska K; Fuchs A; West LJ; Netz H; Belohradsky BH
    Pediatr Transplant; 2011 May; 15(3):272-80. PubMed ID: 21272167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
    Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
    Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.
    McCusker C; Somerville W; Grey V; Mazer B
    Ann Allergy Asthma Immunol; 1997 Aug; 79(2):145-50. PubMed ID: 9291419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients.
    Krüger S; Müller-Steinhardt M; Kirchner H; Kreft B
    Am J Kidney Dis; 2001 Dec; 38(6):1264-70. PubMed ID: 11728959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
    Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
    P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.
    Lin TY; Wang YH; Huang YC; Chiu CH; Lin PY; Chen CJ; Chavand P; Ortiz E
    Int J Infect Dis; 2007 Nov; 11(6):488-95. PubMed ID: 17349809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
    Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
    Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of rituximab therapy on response to tetanus toxoid vaccination in kidney-transplant patients.
    Puissant-Lubrano B; Rostaing L; Kamar N; Abbal M; Fort M; Blancher A
    Exp Clin Transplant; 2010 Mar; 8(1):19-28. PubMed ID: 20199367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to tetanus booster in infants aged 15 months born prematurely with very low birth weight.
    Perin MC; Schlindwein CF; de Moraes-Pinto MI; Simão-Gurge RM; de Mello Almada Mimica AF; Goulart AL; dos Santos AM
    Vaccine; 2012 Oct; 30(46):6521-6. PubMed ID: 22959983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of serologic immunity against vaccine-preventable diseases in children after thoracic transplantation.
    Urschel S; Cremer S; Birnbaum J; Dallapozza R; Fuchs A; Jäger G; Schmitz C; Belohradsky BH; Netz H
    Transpl Int; 2010 Jun; 23(6):619-27. PubMed ID: 20028497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
    Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR
    Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.
    Thisyakorn U; Pancharoen C; Chuenkitmongkol S; Ortiz E
    Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):282-94. PubMed ID: 19323013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
    Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of diphtheria and tetanus vaccination in Gaza, Palestine.
    Al Aswad IH; Shubair ME
    East Mediterr Health J; 2009; 15(2):285-94. PubMed ID: 19554974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to diphtheria booster vaccine in the Baltic states.
    Rønne T; Valentelis R; Tarum S; Griskevica A; Wachmann CH; Aggerbeck H; Plesner AM; Hansen KG; Ricks P
    J Infect Dis; 2000 Feb; 181 Suppl 1():S213-9. PubMed ID: 10657217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immunity against hepatitis B, tetanus, and diphtheria following chemotherapy for hematologic malignancies: a report and review of literature.
    Alavi S; Rashidi A; Arzanian MT; Shamsian B; Nourbakhsh K
    Pediatr Hematol Oncol; 2010 Apr; 27(3):188-94. PubMed ID: 20367262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of a diphtheria, tetanus, acellular pertussis and Haemophilus influenzae Type b combination vaccine compared with separate administration of licensed equivalent vaccines in Chinese infants and toddlers for primary and booster immunization.
    Li G; Zhang H; Zhou W; Ye Q; Li F; Wang H; Hou Q; Xu Y; Ma X; Tan Y; Wang L; Li Y; Li H; Meng F; Liang Q; Liu A; Qin C; Wei W; Liu J; Ruan C; Tao W; Zhang S; Zheng H; Zhu F
    Vaccine; 2010 Jun; 28(25):4215-23. PubMed ID: 20399240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.